Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz

Buy Thyrocare Technologies; Target Of Rs 686: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 686 in its research report dated November 08, 2019.

Nov 13, 2019 / 04:53 PM IST
  • bselive
  • nselive
Todays L/H

Prabhudas Lilladher's research report on Thyrocare Technologies

THYROCAR sales, EBITDA, and PAT increased by 12%, 21%, and 37% YoY. Its higher productivity over the use of RM increased gross margin by 130 bps YoY to 73.2% and reduction in SGA costs increased EBITDA margin by 330 bps YoY to 44.9%in Q2FY20. While employee cost increased by 16% YoY on account of the centers newly started, the productivity of new recruit in H2FY19 helped to increase productivity and reduce employee costs to 10% of revenues in Q2FY20 vs 13% in Q4FY19. Revenue from Diagnostic and imaging testing services increased by 13% and 5% YoY. Revenue growth of 13% is in line with the management guidance for FY20E due to competitive intensity from PE-backed diagnostic centers in B2B segment. Diagnostic services EBIT/EBIT margins increased 18%/190bps YoY while Imaging testing service reported loss of Rs.16mn (18% of Revenues). B2B /B2C revenue increased by 8 % /17% YoY. B2B business contributes more than 75% of the total revenue.


The stock trades at PER of 21.8x and 20.1x FY20E and FY21E respectively. With favorable seasonality Q4FY20E and lower base, we expect THYROCAR to grow at 15% YoY growth in revenues and 21% YoY growth in PAT due to lower tax rate to 25.2% from 34% in FY20E. While diagnostic companies are expected to trade at premium valuation with features of consumer's business, THYROCAR valuation is at sharp discount to its peers. With earnings improvement and attractive valuation vs. peers, we increased our TP to Rs686 (from Rs595) and 'BUY' recommendation.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Nov 13, 2019 04:53 pm

stay updated

Get Daily News on your Browser